According to GUIDE TO LIFE SCIENCES INVESTING "Despite the risks and complexities, investing in Life Sciences can be extremely rewarding from both, commercial and social perspectives. Investing in Life Science companies offers the potential for rewarding financial returns from the select group of companies that achieve commercial success, and investors are also investing in products and research that could potentially save lives, cure diseases, and improve quality of life”. To help companies become 100% investment-ready, we are providing due diligence personalised service. Conducting due diligence on a Life Science company involves evaluating both the business plan and financial projections, as well as assessing the scientific validity of the product. In this service, we will examine the company's management structure, financial strategies, and whether it is developing an innovative product that addresses an unmet need. We will present the company's core business in a way that will be fully understood, where the intellectual property (IP) will support that focus, especially for a newly created start-up company. That said, we will end-up with a company’s value by considering the likelihood that it will meet key milestones on schedule and reach critical value inflection points throughout the development process. For that, we will also gather information on other factors that could impact success, such as collaborative development agreements with other companies or partners, the receipt of grants, the possibility of an expedited development pathway, or any interest shown by a potential acquirer of the company’s technology, and the impact of the regulatory compliance on the development timeline and the approval processes.